Uncategorized

  • |

    MIGS devices lead glaucoma surgical innovation in 2016

    A single event stood out in everyone’s mind when Ophthalmology Times asked experts to think back on the year in glaucoma surgery: the July 29 approval by the U.S. Food and Drug Administration (FDA) of the CyPass Micro-Stent. The CyPass, developed by Transcend Medical of Menlo Park, provides an alternative to the only other minimally invasive glaucoma…

  • |

    About Your Eyes

    Many patients today come to our offices with numerous questions about their eyes, and how they can care for them. Our staff is dedicated to providing the highest level of eye care, and is fully trained in all aspects of eye care. Below you will find many different eye conditions and their descriptions. We hope…

  • |

    Diabetes and The Eye

    Diabetes can lead to damage of the tiny blood vessels inside the retina. Diabetic retinopathy can lead to visual loss if not treated.   Who is at risk for diabetic Retinopathy? All people with diabetes. Every diabetic should have a comprehensive dilated exam once per year. 40-45 percent of Americans with diabetes have diabetic retinopathy….

  • |

    Glaucoma

    What is glaucoma? Glaucoma is a disease of the eye that damages the optic nerve of the eye and can lead to vision loss and blindness. Early detection and treatment is recommended to prevent serious visual loss. The risk factors for glaucoma include: Elevated Intraocular Pressure Optic disc abnormalities Family history of glaucoma African Americans…